FFNTF (4Front Ventures) Quick Ratio: 0.16 (As of Sep. 2024)


FFNTF 4Front Ventures Corp FFNTF
10 GF Score
Price $0.00
View Full Analysis

What is 4Front Ventures Quick Ratio?

4Front Ventures FFNTF -90.00% 10 Quick Ratio is 0.16 as of Sep. 2024. GuruFocus rates FFNTF with a GF Score™ of 10/100.

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. 4Front Ventures's quick ratio for the quarter that ended in Sep. 2024 was 0.16.

4Front Ventures has a quick ratio of 0.16. It indicates that the company cannot currently fully pay back its current liabilities.

The historical rank and industry rank for 4Front Ventures's Quick Ratio or its related term are showing as below:

FFNTF's Quick Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.45
* Ranked among companies with meaningful Quick Ratio only.

4Front Ventures  (OTCPK:FFNTF) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


4Front Ventures Quick Ratio Related Terms


4Front Ventures Quick Ratio Historical Data

* Premium members only.

The historical data trend for 4Front Ventures's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4Front Ventures Quick Ratio Chart

4Front Ventures Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.50 0.71 0.63 0.44 0.16

4Front Ventures Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.17 0.16 0.15 0.16 0.16

FFNTF vs CRYM, PNXP, SKYI: Quick Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, 4Front Ventures's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


4Front Ventures Quick Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, 4Front Ventures's Quick Ratio distribution charts can be found below:

* The bar in red indicates where 4Front Ventures's Quick Ratio falls into.


FFNTF
10GF Score
4Front Ventures Corp FFNTF
Quick Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

4Front Ventures Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

4Front Ventures's Quick Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Quick Ratio (A: Dec. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(33.912-17.087)/104
=0.16

4Front Ventures's Quick Ratio for the quarter that ended in Sep. 2024 is calculated as

Quick Ratio (Q: Sep. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(38.083-19.613)/112.885
=0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Quick Ratio →
What does a Quick Ratio of 0.16 mean?
4Front Ventures (FFNTF) has a Quick Ratio of 0.16 as of Sep. 2024. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on 4Front Ventures and its competitors.
Is 4Front Ventures' Quick Ratio too high?
4Front Ventures' current Quick Ratio is 0.16. The Drug Manufacturers industry median Quick Ratio is 1.45. 4Front Ventures' value of 0.16 is 89% below this industry median. Overall, 4Front Ventures has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does 4Front Ventures' Quick Ratio compare to CRYM and PNXP?
4Front Ventures' Quick Ratio of 0.16 can be compared against companies in the Drug Manufacturers industry. The industry median Quick Ratio is 1.45. 4Front Ventures' value of 0.16 is 89% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 997 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 4Front Ventures's current Quick Ratio of 0.16 is 89% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on 4Front Ventures and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 4Front Ventures's current Quick Ratio is 0.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 4Front Ventures stock overvalued right now?
4Front Ventures (FFNTF) has a current Quick Ratio of 0.16. The current Quick Ratio is 0.16 and 89% below the Drug Manufacturers industry median of 1.45. 4Front Ventures' overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For 4Front Ventures (FFNTF), the current Quick Ratio is 0.16 as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

4Front Ventures Business Description

Address 7010 E. Chauncey Lane, Suite 235, Phoenix, AZ, USA, 85054
4Front Ventures Corp is a Canadian-based company. It is engaged in the cultivation, processing, extracting, manufacturing, and distribution of cannabis products. It operates in two segments: THC Cannabis and CBD Wellness. The THC Cannabis segment engages in the production and cultivation of THC cannabis, manufacturing and distribution of cannabis products to owned dispensaries and third-party retail customers. The CBD Wellness segment encompasses the production and sale of CBD products to third-party customers.
10GF Score

Get the complete analysis for FFNTF

Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price